Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
immunomodulatory progenitor cells (1 trial)
platelet-rich plasma (1 trial)
Fibrosis (Phase 2)
Tennis Elbow (Phase 2)
Trials (2 total)
Trial APIs (2 total)